etilefrine has been researched along with Neurally Mediated Faint in 5 studies
Etilefrine: A phenylephrine-related beta-1 adrenergic and alpha adrenergic agonist used as a cardiotonic and antihypotensive agent.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Etilefrine is an alpha-agonist agent with a potent vasoconstrictor effect, which is potentially useful in preventing vasovagal syncope by reducing venous pooling and/or by counteracting reflex arteriolar vasodilatation." | 2.69 | Effect of etilefrine in preventing syncopal recurrence in patients with vasovagal syncope: a double-blind, randomized, placebo-controlled trial. The Vasovagal Syncope International Study. ( Alboni, P; Brignole, M; Giani, P; Menozzi, C; Moya, A; Raviele, A; Sutton, R, 1999) |
| "Many drugs have been used for the treatment of vasovagal syncope (beta-blockers, disopyramide, scopolamine, clonidine, theophylline, fludrocortisone, ephedrine, dihydroergotamine, etilefrine, midodrine, clonidine, serotonin reuptake inhibitors, enalapril)." | 2.42 | Randomized clinical trials of neurally mediated syncope. ( Brignole, M, 2003) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (40.00) | 18.2507 |
| 2000's | 3 (60.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Liao, Y | 1 |
| Li, X | 1 |
| Zhang, Y | 1 |
| Chen, S | 1 |
| Tang, C | 1 |
| Du, J | 1 |
| Brignole, M | 2 |
| Di Girolamo, E | 1 |
| Di Iorio, C | 1 |
| Sabatini, P | 1 |
| Leonzio, L | 1 |
| Barsotti, A | 1 |
| Raviele, A | 1 |
| Sutton, R | 1 |
| Alboni, P | 1 |
| Giani, P | 1 |
| Menozzi, C | 1 |
| Moya, A | 1 |
| Ammirati, F | 1 |
| Colivicchi, F | 1 |
| Santini, M | 1 |
2 reviews available for etilefrine and Neurally Mediated Faint
| Article | Year |
|---|---|
alpha-Adrenoceptor agonists for the treatment of vasovagal syncope: a meta-analysis of worldwide published data.
Topics: Adrenergic alpha-Agonists; Etilefrine; Humans; Midodrine; Outcome Assessment, Health Care; Randomize | 2009 |
Randomized clinical trials of neurally mediated syncope.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Atenolol; Cardiac Pacing, Artificial; Dou | 2003 |
3 trials available for etilefrine and Neurally Mediated Faint
| Article | Year |
|---|---|
[Evaluation of the effects of diverse therapeutic treatments versus no treatment of patients with neurocardiogenic syncope].
Topics: Adolescent; Adult; Aged; Etilefrine; Evaluation Studies as Topic; Female; Humans; Male; Middle Aged; | 1998 |
Effect of etilefrine in preventing syncopal recurrence in patients with vasovagal syncope: a double-blind, randomized, placebo-controlled trial. The Vasovagal Syncope International Study.
Topics: Adrenergic alpha-Agonists; Adult; Cohort Studies; Disease-Free Survival; Double-Blind Method; Etilef | 1999 |
Effects of intravenous etilefrine in neurocardiogenic syncope induced by head-up tilt testing.
Topics: Adrenergic Agonists; Adult; Etilefrine; Female; Hemodynamics; Humans; Injections, Intravenous; Male; | 2000 |